Twist Bioscience Corp (TWST):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Twist Bioscience Corp (TWST) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10492
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Twist Bioscience Corp (Twist Bioscience) is a provider of synthetic DNA Tools. Its silicon-based DNA synthesis platform enables precise synthesis and sequencing process and production of synthetic DNA tools. The company offers its products which include DNA tools for gRNA cloning such as unamplified oligo pools, cloning-ready oligo pools; protein scanning single variant libraries, clonal perfect genes and non-clonal fragments, target enrichment solutions, DNA data storage, among others. The company’s products are used in the fields of medicine, agriculture, industrial chemicals and data storage. The company operates in the US, Europe, Israel, and Singapore. Twist Bioscience is headquartered in San Francisco, California, the US.

Twist Bioscience Corp (TWST) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Twist Bioscience Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Twist Bioscience Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Twist Bioscience Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Twist Bioscience Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Twist Bioscience Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Twist Bioscience Corp, Medical Equipment, Deal Details 10
Partnerships 10
Twist Bioscience Enters into Licensing Agreement with Oxford Genetics 10
IntegraGen Enters into Distribution Agreement with Twist Bioscience 11
Equity Offering 12
Twist Bioscience Prices IPO of Shares for USD70 Million 12
Twist Bioscience Raises USD1 Million in Private Placement of Series D Preferred Shares 13
Twist Bioscience Raises USD11 Million in Private Placement of Series D Preferred Shares 14
Twist Bioscience Raises USD50 Million in Private Placement of Shares 15
Twist Bioscience Corp – Key Competitors 16
Twist Bioscience Corp – Key Employees 17
Twist Bioscience Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Oct 24, 2018: Twist Bioscience names Ray Tabibiazar, M.D., as senior vice president, corporate development and business strategy 19
Jun 20, 2018: Twist Bioscience Appoints Jim Thorburn CFO And Aaron Sato As CSO Of Pharma 20
Legal and Regulatory 21
Oct 29, 2018: Agilent sends letter to the SEC regarding Material Misstatements in Twist Bioscience’s S-1 registration statement 21
Government and Public Interest 22
Sep 18, 2018: Twist Bioscience Responds to Agilent’s Latest Specious Claims 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Twist Bioscience Corp, Medical Equipment, Key Facts 2
Twist Bioscience Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Twist Bioscience Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Twist Bioscience Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Twist Bioscience Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Twist Bioscience Corp, Deals By Market, 2012 to YTD 2018 8
Twist Bioscience Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Twist Bioscience Enters into Licensing Agreement with Oxford Genetics 10
IntegraGen Enters into Distribution Agreement with Twist Bioscience 11
Twist Bioscience Prices IPO of Shares for USD70 Million 12
Twist Bioscience Raises USD1 Million in Private Placement of Series D Preferred Shares 13
Twist Bioscience Raises USD11 Million in Private Placement of Series D Preferred Shares 14
Twist Bioscience Raises USD50 Million in Private Placement of Shares 15
Twist Bioscience Corp, Key Competitors 16
Twist Bioscience Corp, Key Employees 17
Twist Bioscience Corp, Other Locations 18
Twist Bioscience Corp, Subsidiaries 18

List of Figures
Twist Bioscience Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Twist Bioscience Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Twist Bioscience Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Twist Bioscience Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Twist Bioscience Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Twist Bioscience Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Twist Bioscience Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Twist Bioscience Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Twist Bioscience Corp (TWST):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • eNeura Inc:医療機器:M&Aディール及び事業提携情報
    Summary eNeura Inc (eNeura) formerly eNeura Therapeutics LLC is a medical device manufacturing company that offers portable, non-invasive transcranial magnetic stimulation devices for treating migraine. The company offers products such as flagship product and eNeura Spring TMS device, among others. …
  • AvidBiotics Corp-製薬・医療分野:企業M&A・提携分析
    Summary AvidBiotics Corp (AvidBiotics) is a healthcare company that develops non-antibody proteins targeting cancer, bacteria and virus-infected cells. The company develops a portfolio of therapeutic protein candidates and protein engineering platforms which include avidocin proteins, mica-body prot …
  • Aeglea BioTherapeutics Inc (AGLE)-製薬・医療分野:企業M&A・提携分析
    Summary Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company’s product pipeline comprises AEB1102, AEB …
  • Clarins SA:企業の戦略・SWOT・財務情報
    Clarins SA - Strategy, SWOT and Corporate Finance Report Summary Clarins SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Lydall Inc (LDL):企業の財務・戦略的SWOT分析
    Lydall Inc (LDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Lamprell Plc (LAM):企業の財務・戦略的SWOT分析
    Lamprell Plc (LAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • BlueRock Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary BlueRock Therapeutics is a biotechnology company that develops novel stem cell therapies to treat cardiovascular and neurodegenerative diseases. The company’s therapeutic candidate is used to treat Parkinson’s disease that restores dopamine production in the midbrain by retaining dopamine-se …
  • Antero Resources Corp (AR):企業の財務・戦略的SWOT分析
    Antero Resources Corp (AR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Duchesnay Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Duchesnay Inc (Duchesnay) is a pharmaceutical company that offers medications for use in pregnancy. The company’s products include diclectin, an antinauseant drug used for the management of nausea and vomiting; pregvit, a supplement that allow attaining nutrient levels of folic acid, iron, a …
  • Marina Portoroz d.d.:企業の戦略・SWOT・財務情報
    Marina Portoroz d.d. - Strategy, SWOT and Corporate Finance Report Summary Marina Portoroz d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Consumers Energy Co:企業の発電所・SWOT分析2018
    Consumers Energy Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Proximus plc (PROX):企業の財務・戦略的SWOT分析
    Proximus plc (PROX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Getinge AB (GETI B):医療機器:M&Aディール及び事業提携情報
    Summary Getinge AB (Getinge) is a medical technology company that designs, develops and markets equipment and instruments in the areas of surgery, infection control, intensive care, care ergonomics and wound care. Its major products include surgical tables, lights, ventilators and anesthesia equipme …
  • Iwatani Corporation (8088):企業の財務・戦略的SWOT分析
    Iwatani Corporation (8088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Highmark Inc-製薬・医療分野:企業M&A・提携分析
    Summary Highmark Inc (Highmark), a subsidiary of Highmark Health, is a provider of healthcare insurance solutions. The company underwrites various indemnities and offers healthcare insurance products to individuals, families, groups, companies and federal employees. In addition, the company provides …
  • Valener Inc (VNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Valener Inc (Valener) is an investment holding company that focuses on the energy sector. Through its investments in energy portfolio, the company offers storage, distribution, transportation and allied energy services. The company has interest in Gaz Metro and is its limited partner. Gaz Me …
  • Centrica Plc (CNA):石油・ガス:M&Aディール及び事業提携情報
    Summary Centrica Plc (Centrica) is an integrated energy company. It carries out electricity generation through and combined cycle gas turbine (CCGT) power stations, and nuclear power plants through its stake in EDF Energy Nuclear Generation. Centrica secures and supply gas and electricity to homes a …
  • China Resources Pharmaceutical Group Ltd (3320)-製薬・医療分野:企業M&A・提携分析
    Summary China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise ch …
  • Toyota Industries Corporation:企業の戦略・SWOT・財務分析
    Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • FibroGen Inc (FGEN)-製薬・医療分野:企業M&A・提携分析
    Summary FibroGen Inc (FibroGen) is a biotechnology company that discovers, develops and commercializes new therapeutics. The company’s pipeline product portfolio includes FG-4592, an oral small molecule inhibitor of HIF prolyl hydroxylases that is used for the treatment of anemia in chronic kidney d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆